Emgality Approved to Treat Episodic Cluster Headache in Adults
The FDA has approved Emgality (galcanezumab-gnlm; Lilly) for injection for the treatment of episodic cluster headache in adults.
The FDA has approved Emgality (galcanezumab-gnlm; Lilly) for injection for the treatment of episodic cluster headache in adults.
The Food and Drug Administration has cleared the ZIKV Detect 2.0 lgM Capture ELISA (InBios) for testing of Zika virus immunoglobulin antibodies in blood.
This noninferiority trial showed no more chronic sleep loss or sleepiness across trial days among interns in flexible programs than among those in standard programs.
The American Academy of Pediatrics has approved the 2019 Recommendations for Preventive Pediatric Health Care, also known as the Periodicity Schedule.
From 2011 to 2017 the number of kratom related calls to US Poison Control Centers went from about 1 a month to 2 a day; the finding comes from an analysis of the National Poison Data System.
Please login or register first to view this content.